{
    "version": "1.0",
    "type": "rich",
    "width": 0,
    "height": 0,
    "html": false,
    "provider_name": "ReleaseWire",
    "provider_url": "http:\/\/www.releasewire.com\/",
    "title": "PARP (Poly ADP-Ribose Polymerase) Inhibitors Market: CLOVIS ONCOLOGY, AbbVie Inc., Pfizer Inc., AstraZeneca, and TESARO, Inc",
    "author_name": "TMR Research",
    "author_url": "https:\/\/www.tmrresearch.com\/"
}